Previous 10 | Next 10 |
2023-04-17 07:11:02 ET Amarin ( NASDAQ: AMRN ) announced on Monday the appointment of Aaron Berg as interim president and CEO, effective immediately. Berg, who has more than 25 years of biopharmaceutical industry experience, currently serves as Amarin's executive vice pres...
DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company’s Board of Directors has appointed Aaron Berg, currently Amarin’s Executive Vice President and President of the U.S. Business, as Interim P...
2023-04-16 09:15:01 ET Summary Sarissa Capital has taken full control of Amarin. The previous management was doing some slow but decent work, but did not get time to show results. Sarissa hasn't disclosed material plans. In February, I wrote that while Amarin ( ...
2023-04-04 15:53:30 ET U.S. stock markets are under heavy pressure today after two reports on job openings and factory orders came in weaker than expected. The key issue at play is a growing concern that the Federal Reserve's rate hiking campaign may spark a deep and long-lasting economic d...
2023-04-04 08:35:01 ET Ireland-based biotech Amarin Corporation ( NASDAQ: AMRN ) added ~5% pre-market Tuesday after announcing that Israel’s Ministry of Health approved its fish oil-derived heart disease therapy Vazkepa (icosapent ethyl). Accordingly, Vazkepa will b...
-- Approval of VAZKEPA® to Reduce the Risk of Cardiovascular (CV) Events in Adult Statin-Treated Patients at High CV Risk with Elevated Triglycerides and Other High-Risk Characteristics as Studied in REDUCE-IT –- -- Heart Disease Second Leading Cause of Death in Men and Wome...
2023-03-31 09:18:55 ET Ireland-based biotech Amarin Corporation ( NASDAQ: AMRN ) announced Friday that President and Chief Executive Officer Karim Mikhail has decided to step down, effective immediately. Amarin ( AMRN ), the developer of fish oil-derived therapy Vascep...
New Amarin Board Believes the Company Will Thrive with Proper Stewardship New Amarin Directors are Working with Urgency to Address Issues at Amarin DUBLIN, Ireland and BRIDGEWATER, N.J., March 16, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today released the fo...
2023-03-08 18:12:02 ET Amarin Corporation plc (AMRN) Cowen 43rd Annual Healthcare Conference March 08, 2023, 01:30 PM ET Company Participants Karim Mikhail - President and CEO Conference Call Participants Georgi Yordanov - Cowen and Company Presentation...
2023-03-07 10:26:05 ET The following slide deck was published by Amarin Corporation plc in conjunction with their 2022 Q4 earnings call. For further details see: Amarin Corporation plc 2022 Q4 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
2024-07-31 14:15:16 ET Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q2 2024 Earnings Call Jul 31, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript
Dayforce Inc. (DAY) is expected to report $0.18 for Q2 2024 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.44 for Q2 2024 Aurora Innovation Inc. (AUR) is expected to report for Q2 2024 Autohome Inc. American Depositary Shares each repr...
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...